Logo

Some Drugs and Herbal Products

Small book cover: Some Drugs and Herbal Products

Some Drugs and Herbal Products

Publisher: International Agency for Research on Cancer
Number of pages: 438

Description:
This volume of the IARC Monographs provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin (widely prescribed for the treatment of chronic heart failure), pioglitazone (used for the treatment of type 2 diabetes mellitus), and hydrochlorothiazide (used to treat hypertension).

Home page url

Download or read it online for free here:
Download link
(8.7MB, PDF)

Similar books

Book cover: Mammography Techniques and ReviewMammography Techniques and Review
by - InTech
Mammography remains at the backbone of medical tools to examine the human breast. The early detection of breast cancer typically uses adjunct tests to mammogram such as ultrasound, positron emission mammography, electrical impedance, and others.
(3648 views)
Book cover: Who Survives Cancer?Who Survives Cancer?
by - University of California Press
Addressed to health-care professionals and policymakers, this book makes it clear that we are not winning the war against cancer. The author looks at how class, race, sex, and available treatments can affect one's chances of survival.
(10332 views)
Book cover: Ovarian Cancer: The Recognition and Initial ManagementOvarian Cancer: The Recognition and Initial Management
- National Collaborating Centre for Cancer
These clinical guidelines review a number of clinical questions that involve the detection, diagnosis and initial management of ovarian cancer and which focus on areas of uncertainty or where there is a wide variation in clinical practice.
(5842 views)
Book cover: Prostate Cancer: Diagnosis and TreatmentProstate Cancer: Diagnosis and Treatment
- National Collaborating Centre for Cancer
Prostate cancer is one of the commonest cancers in men. There is evidence of practice variation around the country and of patchy availability of certain treatments. The guideline will help to address these issues and offer guidance on best practice.
(5789 views)